Medicinal Products Act (HMG)(812.102).

This law provides the legal basis for the authorization, distribution, and monitoring of human and veterinary medicinal products and medical devices in Liechtenstein. It ensures that only products meeting strict safety, efficacy, and quality standards are allowed on the market. It mandates ongoing surveillance of authorized products to monitor their safety and effectiveness, and to ensure compliance with regulatory requirements. The HMG aligns Liechtenstein's regulations with European Union directives, facilitating the mutual recognition of authorizations and standards across EU member states. This legislation is part of Liechtenstein's efforts to ensure high standards in the healthcare sector, protect public health, and harmonize its laws with those of the European Union. The text consists of 61 Articles.